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Abstract
Objectives To compare right gastric (RGA) and segment 4
artery (A4) origin detection rates during radioembolisation
workup between early and late arterial phase liver CT
protocols.
Methods 100 consecutive patients who underwent liver CT
between May 2012–January 2015 with early or late arterial
phase protocol (n=50 each, 10- vs. 20-s post-threshold delay)
were included. RGA/A4 origin detection rates, assessed by
two raters, and contrast-to-noise ratio (CNR) of the hepatic
artery relative to the portal vein were compared between the
protocols.
Results The first–second rater scored the RGA origin as vis-
ible in 58–65 % (specific proportion of agreement 82 %,
κ=0.62); A4 origin in 96–89 % (94 %, κ=0.54). Thirty-six
percent of RGA origins not detectable by DSAwere identified
on CT. Origin detection rates were not significantly different
for early/late arterial phases. Mean CNR was higher in the
early arterial phase protocol (1.7 vs. 1.2, p<0.001).
Conclusion A 10-s delay arterial phase CT protocol does not
significantly improve detection of small intra- and extrahepat-
ic branches. RGA origin detection requires further optimiza-
tion, whereas A4/MHA origin detection is adequate, with
good inter-rater reproducibility. CT remains important for
preprocedural planning, because it may reveal arterial anato-
my not discernible on DSA.
Key Points
• An early arterial phase does not significantly improve RGA
and A4/MHA origin detection.
• RGA origin detection (58–65 %) on CT is still suboptimal.
• 36 % of RGA origins undetectable on DSA can be identified
on CT.
• A4/MHA origin detection (89–96 %) on CT is excellent.
• Inter-rater reproducibility is good for RGA and A4/MHA
origin detection on CT.
Keywords Radioembolisation . SIRT . Liver CT .
Acquisition protocol . Arterial phase
Abbreviations
aLHA/aRHA Accessory LHA/RHA
CHA Common hepatic artery
CNR Contrast-to-noise ratio
CECT Contrast-enhanced computed tomography
DSA Digital subtraction angiography
GDA Gastroduodenal artery
LHA Left hepatic artery
CT Computed tomography
MHA Middle hepatic artery
PHA Proper hepatic artery
rCHA Replaced CHA
RGA Right gastric artery
RHA Right hepatic artery
rLHA/rRHA Replaced LHA/RHA
A4 Segment 4 artery
SD Standard deviation
* Andor F. van den Hoven
a.f.vandenhoven@umcutrecht.nl
1 Department of Radiology and Nuclear Medicine, University Medical
Center Utrecht, Heidelberglaan 100, 3584
CX Utrecht, The Netherlands
Eur Radiol (2017) 27:61–69
DOI 10.1007/s00330-016-4343-1
SNR Signal-to-noise ratio
SPA Specific proportion of agreement
Introduction
Radioembolisation has evolved as a safe and effective treat-
ment option in patients with liver tumours that are not resect-
able and are refractory to standard systemic therapy [1]. Since
this treatment encompasses the injection of radioactive micro-
spheres via a microcatheter positioned in the hepatic arteries, it
is essential to perform a thorough assessment of the hepatic
arterial anatomy before treatment [2].
Intra-procedural imaging with digital subtraction angi-
ography (DSA) has long been considered the gold stan-
dard for vascular evaluation [3]. However, since modern
multidetector computed tomography (CT) scanners enable
high-resolution, multiphasic, multiplanar imaging of the
liver, the arterial vasculature can already be evaluated on
CT before the pretreatment angiography. This has two
distinctive advantages. First, in contrast to DSA, CT im-
ages can depict the spatial relation between arterial
branches and liver parenchyma or gastrointestinal organs
in three dimensions, at high resolution, with a wide field
of view. Most importantly, though, timely assessment of
the anatomy enables the establishment of a treatment
strategy ahead of time, and results in increased time effi-
ciency and operator confidence during the treatment pro-
cedure [4].
In our centre, a standardized triphasic liver CT protocol
encompassing a late arterial, portal venous and equilibrium
phase had been used to evaluate the liver parenchyma and
vasculature in all patients with liver malignancies, including
radioembolisation candidates [4–6]. The imaging delay of the
arterial phase (post-threshold delay of 20 s) was chosen to
allow for detection of hypervascular tumours, but it is ques-
tionable whether a late arterial phase is best suited for evalu-
ation of the arterial vasculature.
We noticed in clinical practice that contrast enhancement
of the portal vein often obscures the origin of small arterial
branches that need to be identified, especially the right gas-
tric artery (RGA) and segment 4 artery (A4). An early arte-
rial phase with a delay of 10 s may reveal the RGA and A4
origin better due to a higher contrast-to-noise ratio (CNR)
of the hepatic artery relative to the portal vein. Furthermore,
it remains uncertain how well the RGA and A4 origins can
be visualized on liver CT in the population of heavily
pretreated radioembolisation patients, and how reproduc-
ible these observations are when comparing different raters.
Hence, the purpose of this study was to compare RGA and
A4 origin detection rates during radioembolisation workup
between early and late arterial phase liver CT protocols, and
to determine inter-rater reproducibility.
Methods
Study design
We performed a prospective development study in accordance
with the IDEAL recommendations [7]. A triphasic liver CT
(henceforth referred to as standard protocol) was already part
of our routine workup for radioembolisation. The majority of
our radioembolisation candidates have hypovascular tumour
types. Thus, evaluation of the hepatic arterial anatomy is the
primary purpose of the arterial liver CT phase in these pa-
tients, while the portal venous phase is used for tumour detec-
tion and localization. To improve the visualization of small
arterial branch origins, we adjusted our liver CT protocol
(henceforth referred to as adjusted protocol). The performance
of the adjusted scan protocol was tested by using a historical
cohort of patients previously scanned with the standard proto-
col as comparison.
The medical ethics committee of our institution approved this
study and waived the need for informed consent for reviewing
imaging data on radioembolisation patients in our centre.
Study population
A total of 100 patients (50 patients for each of the protocols)
would be required to demonstrate a 30 % difference in RGA
detection rate (80 % for the adjusted protocol vs. 50 % for the
standard protocol) with a power of 0.90, at an alpha-level of
0.05 (sample size calculation with ‘Power and Sample Size
Calculation’ version 3.1.2 for MacOsX).
All patients with unresectable and chemorefractory liver
tumours who underwent a pretreatment liver CT in combina-
tion with an 18F-FDG-PET scan on the same CT scanner,
before undergoing a preparatory angiography as part of the
radioembolisation workup, were eligible for study participa-
tion. Starting in December 2013, 50 consecutive patients were
selected for the adjusted liver CT protocol. A group of 50
consecutive patients who had been scanned earlier using the
standard protocol was selected for comparison. Patients with a
technical scan failure or those without a preparatory angiog-
raphy were excluded. Baseline patient characteristics for both
groups were compared to ensure a valid comparison.
Technique, equipment and scan settings
On the day before the examination, all patients received 1,
000 ml of water-soluble contrast solution (Telebrix Gastro
300 mg/ml) orally to enhance the detection of peritoneal disease
and lymphadenopathy. In the adjusted protocol, mannitol solu-
tion (100 ml, 15%) was given orally before the scan to stimulate
gastric emptying and create a negative contrast with adjacent
contrast-enhanced vessels. Subsequently, 150–185 ml (depend-
ing on body weight) iopromide 300 mg/ml contrast agent
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(Ultravist, Bayern Schering Pharma AG, Berlin, Germany) was
injected with a double syringe injector in the antecubital vein at a
rate of 5 ml/s, followed by a 50-ml NaCl chaser.
All CT scans were acquired under breath-hold on an inte-
grated PET/CT scanner (Biograph mCT, Siemens Healthcare,
Erlangen, Germany) with 40 detector rows, using a matrix size
of 512×512, rotation time of 0.4–0.5 s, pitch of 0.9–1.2, and
fixed 120 kV tube potential.
The standard protocol consisted of a late arterial, portal-
venous and an equilibrium phase, which were obtained with a
post-threshold (abdominal aorta enhancement >100
Hounsfield units (HU)) delay of 20, 55 and 300 s, respective-
ly. A tube current of 150 mAs was used in the arterial and
equilibrium phase, and 225 mAs for the portal-venous phase.
Slice thickness/increment were 0.9/0.7 cm for the arterial
phase, and 1.5/1.0 cm for the portal-venous and equilibrium
phase.
The adjusted protocol consisted of an arterial phase with a
shortened post-threshold delay of 10 s, and an unchanged
timing of the portal-venous phase. No equilibrium phase
was acquired.
In this protocol, tube current was dependent on the weight
of the patient: 150 mAs in patients <85 kg, and 200 mAs in
patients ≥85 kg. In all phases, slice thickness/increment was
0.9/0.7 mm.
The technique used during the preparatory angiography has
been published before and conforms to current standards of
clinical practice [8, 9]. Digital subtraction angiography (DSA)
images were acquired on an Allura Xper FD20 system
(Philips, Best, The Netherlands).
Image analyses
All images were anonymized and loaded into OsiriX (version
5.8, 32-bit, MacOS X) for image analyses.
Two independent raters, an abdominal radiologist (MB)
and an interventional radiologist (PJvD), were asked to
score the following: visibility of the RGA origin (yes/
no), location of the RGA origin (arrow appointing the
region of interest), visibility of the A4/MHA origin (yes/
no), location of the A4/MHA origin/origins (arrow), and
ability to distinguish two separate branches to S4a and
S4b (yes/no). The raters were instructed to score the ori-
gin as not visible when in doubt.
The origins were evaluated on the thin slices (1 mm thick-
ness/0.7 mm increment). Use of a maximum intensity projec-
tion (MIP) with a reconstructed slice thickness of 4 mm and/or
the use of multiplanar reconstruction was optional. Scans of
patients who had previously undergone surgery in which the
RGA was sacrificed or segment 4 was resected were consid-
ered non-evaluable.
The A4 was termed a middle hepatic artery (MHA) when
originating in between a (r)left hepatic artery (LHA) and
(r)right hepatic artery (RHA), as a branch from the common
hepatic artery (CHA) or proper hepatic artery (PHA). No true
PHA exists in patients with an aberrant hepatic artery, there-
fore the RGA or A4 origin was called after the non-aberrant
arterial branch if originating distal to the origin of the gastro-
duodenal artery (GDA) [4].
A third rater (AvdH) independently scored the origin of
the RGA on DSA to establish a reference standard for
correct identification of the RGA origin on CT. This was
not done for the A4 score, since the lack of topographical
landmarks on DSA makes distinguishing liver segments
challenging. Unfortunately, C-arm CT images were not
available in all patients. The third rater also assessed the
individual hepatic arterial anatomy as described earlier
[4], and measured the signal-to-noise ratio (SNR) of the
hepatic arteries and portal veins, as well as the CNR of
the hepatic arteries relative to the portal vein. Circular
regions of interest (ROIs) with a diameter of 3–6 mm
were drawn in the hepatic artery and the portal vein at
approximately the same level in the liver hilum on axial
slice MIP (8-mm reconstructed slice thickness) images of
the arterial phase, and the mean and standard deviation
(SD) of the signal (in HU) were noted. The following
equations were used:
SNR ¼ Mean HUð Þ
SD HUð Þ ð1Þ








Descriptive analyses were performed to give an overview
of baseline patient characteristics, and RGA/A4 origin lo-
cations. Data with normal and non-normal distributions
are presented as mean ± standard deviation and median
(range).
A two-sided unpaired Student’s t-test was used to test for
differences in mean arterial and portal SNR, and mean CNR,
between the standard and the adjusted protocol.
A chi-square test was used to compare the standard proto-
col and the adjusted protocol with regard to the rate of correct
RGA origin localization (using DSA as a reference standard),
and A4 origin detection.
A specific proportion of agreement and kappa statistics
were used to indicate inter-rater agreement and reliability for
the RGA and A4 origin detection.
All analyses were performed with R Studio version
0.98.1102 for MacOsX. A p-value <0.05 was considered sta-
tistically significant.
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Results
Patients and scans
Between December 2013 and January 2015, 58 patients
were scanned according to the adjusted protocol for liver
CT, and were found eligible for inclusion in this study.
Eight of these patients were excluded either because the
scan was performed on another CT scanner (n = 6) or be-
cause no angiography was performed (n = 2). Between
May 2012 and December 2013, 63 patients had undergone
a standard triphasic liver CT. Twelve of these patients were
not selected for the control group because the scan was
acquired on another CT scanner (n = 9), no angiography
was performed (n = 2) or technical failure of the CT scan
occurred (n = 1). The two groups were comparable with
regard to baseline patient characteristics and hepatic arte-
rial anatomy (Tables 1 and 2).
Origin of the right gastric artery (RGA)
Five scans (standard protocol n=4, adjusted protocol n=1)
were not evaluable for the assessment of the RGA origin, due
to previous gastric (n=4) or pancreatic (n=1) surgery involv-
ing the RGA, leaving 46 scans evaluable for the standard
protocol and 49 scans for the adjusted protocol (see Fig. 1
for a clinical example of both protocols).
The RGA origin was visible in 70/95 patients (74 %) on
DSA, and in 55/95 (58 %) and 62/95 (65 %) on CT for
raters 1 and 2, respectively (Table 3). This corresponds to
the following test characteristics for CT, taking DSA as a
reference standard (range for raters 1–2): positive-
predictive value 84–85 %, negative-predictive value 40–
48 %, false-positive rate 36–36 %, false-negative rate 24–
34 %. Thus, both raters recognized the RGA origin on CT
in nine of the 25 (36 %) patients in whom it was not visible
on DSA.
The RGA origin was correctly localized on CT (taking
DSA as reference standard) by rater 1 in 54 % and 69 % of
patients scanned with the standard and adjusted protocols,
respectively (p=0.19); for rater 2, this was 65 % and 69 %,
respectively (p=0.83).
The specific proportion of agreement in CTscores between
the two raters was 78/95 (82 %), and the reliability was sub-
stantial with a Cohen’s kappa of 0.62 (confidence limits 0.46–
0.78). Both raters appointed the same RGA origin in all cases
with a visible RGA on CT. According to the CT scores of
raters 1–2, the RGA originated from the LHA in 47–51 % of
patients, PHA in 21–23 %, CHA in 10–13 %, GDA in 5–9 %,
RHA in 6–8 %, A4/MHA in 3–4 % and superior mesenteric
artery (SMA) in 2 %.
Table 1 Baseline patient
characteristics Characteristic Entire cohort (n = 100) Standard protocol (n = 50) Adjusted protocol (n = 50)
Age, years 64± 10 63 ± 11 65± 11
Gender
Male 54 (54 %) 24 (48 %) 30 (60 %)
Female 46 (46 %) 26 (52 %) 20 (40 %)
BMI 27± 4 27 ± 5 27± 4
Liver tumour burden
<25 % 83 (83 %) 42 (84 %) 41 (82 %)
25–50 % 12 (12 %) 6 (12 %) 6 (12 %)
>50 % 5 (5 %) 2 (4 %) 3 (6 %)
Liver tumour type
CRC 66 (66 %) 31 (62 %) 35 (70 %)
Cholangiocarcinoma 11 (11 %) 6 (12 %) 5 (10 %)
Uvea melanoma 8 (8 %) 4 (8 %) 4 (8 %)
Mammaca 5 (5 %) 3 (6 %) 2 (4 %)
Other 10 (10 %) 6 (12 %) 4 (8 %)
Previous surgery involving
A4 6 (6 %) 2 (4 %) 4 (8 %)
RGA 5 (5 %) 4 (8 %) 1 (2 %)
The baseline patient characteristics are summarized in this table, for the entire cohort and for both protocols
separately
Values are given as mean ± standard deviation or number of patients (percentage of total)
BMI body mass index, CRC, RGA right gastric artery
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Table 2 Individual hepatic






Standard anatomy 54 (54 %) 29 (58 %) 25 (50 %)
Early branching pattern 19 (19 %) 9 (18 %) 10 (20 %)
Early branching LHA 2 (2 %) 1 (2 %) 1 (2 %)
Early branching RHA 1 (1 %) 0 1 (2 %)
Trifurcation of CHA 13 (13 %) 7 (14 %) 6 (12 %)
Quadrifurcation of CHA 3 (3 %) 1 (2 %) 2 (4 %)
Aberrant hepatic arteries 27 (27 %) 12 (24 %) 15 (30 %)
rLHA [LGA, S2-3] 8 (8 %) 2 (4 %) 6 (12 %)
rLHA [LGA, S2-4] 2 (2 %) 1 (2 %) 1 (2 %)
aLHA [LGA, S2] 2 (2 %) 1 (2 %) 1 (2 %)
rRHA [SMA, S5-8] 9 (9 %) 5 (10 %) 5 (10 %)
rRHA [SMA, S4-8] 0 0 0
aRHA [SMA, S5+8] 1 (1 %) 0 1 (2 %)
rLHA + rRHA [SMA, S5-
8]
1 (1 %) 0 1 (2 %)
rCHA [SMA] 4 (4 %) 3 (6 %) 1 (2 %)
The hepatic arterial configuration is summarized in this table, for the entire cohort and for both protocols
separately
Values are given in number of patients (percentage of total)
Aberrant hepatic arteries are indicated as type of variant [origin, segmental vascularisation pattern]
LHA left hepatic artery, RHA right hepatic artery, CHA common hepatic artery, SMA superior mesenteric artery
Fig. 1 a-d Comparison of
maximum intensity projections of
liver CT images with the standard
(a, c) and the adjusted arterial
phase protocol (b, d) in the same
patient, acquired on the same
scanner. Note that the adjusted
protocol is easier to evaluate due
to an increased contrast-to-noise
ratio for the hepatic artery relative
to the portal vein, but the origins
of the A4 (a, b, black arrow) and
the right gastric artery (c, d, white
arrow) are nonetheless visible in
both protocols
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Origin of the A4/middle hepatic artery (MHA)
Six scans (standard protocol n=2, adjusted protocol n=4)
were not evaluable for the assessment of the A4/MHA origin,
due to previous liver surgery involving segment 4, leaving 48
scans evaluable for the standard protocol and 46 scans for the
adjusted protocol.
The first and second rater scored the origin of the A4/MHA
as visible in 90/94 (96 %) and 84/94 (89 %), respectively
(Table 4). The detection rate of the A4/MHA origin did not
differ significantly between the standard and the adjusted pro-
tocol: 96 % versus 96 % scored by rater 1, and 87 % versus
91 % (p=0.79) scored by rater 2.
The specific proportion of agreement in visibility of the
A4/MHA origin between the two raters was 88/94 (94 %).
The reliability was moderate; Cohen’s kappa was 0.54 (confi-
dence limits 0.23–0.86). There was a disagreement between
the two raters in the appointedA4/MHA origin location on CT
in four patients.
According to raters 1–2, segment 4 was vascularized ex-
clusively by an A4 originating from the LHA in 56–57 % of
patients, from the RHA in 27–28 %, from a rLHA in 1–2 %
and never from a rRHA. An MHA originated from the CHA
in 4–5 % of patients, and from the PHA in 3–5 %. A dual-type
A4 originated from the LHA + RHA in 4–5 % of patients, and
from a rLHA + RHA in 1 %.
Raters 1 and 2 indicated that they could clearly distinguish
two separate arterial branches to the superior (S4a) and infe-
rior (S4b) parts of S4 in 18/94 (19 %) and 10/94 (11 %) of
patients. These two branches originated from a different main
hepatic arterial branch (LHA + RHA or rLHA + RHA) in five
of these patients, and originated from the same main hepatic
arterial branch in the rest of the cases.
Signal-to-noise (SNR) and contrast-to-noise (CNR) ratios
Themean arterial SNRwas not different for the two protocols:
7.5 and 7.4 for the adjusted protocol and the standard protocol,
respectively (95 % confidence interval (CI) for the difference
in means: −1.2 to 1.5; p=0.83). The mean portal SNR was
significantly lower in the adjusted protocol compared with the
standard protocol: 7.4 versus 9.7 (95%CI for the difference in
means: −3.2 to −1.3; p=8.9×10-6). This resulted in a signif-
icantly higher mean CNR of the hepatic arteries relative to the
portal vein in the adjusted protocol: 1.7 versus 1.2 (95 % CI
for the difference in means: 0.4–0.7; p=4.9×10-11).
Discussion
The purpose of this study was to compare RGA and A4/MHA
origin detection rates during radioembolisation workup be-
tween early and late arterial phase liver CT protocols, and to
determine inter-rater reproducibility. The adjusted protocol
with the early arterial phase did not significantly improve
the detection rate of small intra- and extrahepatic branches,
despite a higher CNR of the hepatic arteries relative to the
portal vein. Furthermore, the RGA origin detection was lower
than that of the A4 (58–65 % vs. 89–96 %) in our study.
However, when identified, the inter-rater agreement of the
origin localization was high for both the RGA (82 %) and
A4 (94 %). The inter-rater reliability was moderate and sub-
stantial, respectively.
The overall RGA origin detection rate on CT (around
60 %) can be considered suboptimal. By comparison with
DSA, we found a low negative-predictive value (40–48 %)
and relatively high false-negative rate (24–34 %), indicating
that the inability to find the RGA origin on CT does not sig-
nify the same for DSA. The RGA origin may not be visualized
on CT because of a small calibre, an intimate anatomical
course parallel to another branch, flow dynamics prohibiting
contrast filling or the presence of metal artefacts. The high
positive-predictive value (84–85 %), and good inter-rater
agreement, on the other hand, suggest that the necessity to
coil-embolize the RGA or advance the microcatheter beyond







Origin of RGA visible?
Yes 70 (74 %) 55 (58 %) 62 (65 %)
No 25 (26 %) 40 (42 %) 33 (35 %)
RGA origins
CHA 6 (9 %) 8 (15 %) 7 (11 %)
GDA 3 (4 %) 5 (9 %) 3 (5 %)
PHA 18 (26 %) 11 (21 %) 15 (24 %)
LHA 35 (49 %) 26 (47 %) 29 (47 %)
A4/MHA 3 (5 %) 2 (4 %) 2 (3 %)
RHA 5 (7 %) 3 (6 %) 5 (8 %)





RGA origin correctly identified on CT (DSA as reference test)
Rater 1 25 (54 %) 34 (69 %)
Rater 2 30 (65 %) 34 (69 %)
The RGA origin and its detection rate is summarized for DSA and CT
(both raters) in this table
Values are given in number of patients (percentage of total)
No true PHA exists in patients with an aberrant hepatic artery, therefore,
the RGA was called after the non-aberrant arterial branch if originating
distal to the origin of the GDA
DSA digital subtraction angiography, CHA common hepatic artery, GDA
gastroduodenal artery, PHA proper hepatic artery, LHA left hepatic artery,
MHAmiddle hepatic artery, RHA right hepatic artery, SMA superior mes-
enteric artery
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its origin to avoid harmful extrahepatic deposition of radioac-
tive microspheres, can already be evaluated in patients with a
visible origin of the RGA on pretreatment liver CT. Besides,
the RGA origin was revealed by CT in 36 % of the patients in
whom DSA failed to show it. Thus, assessing the RGA origin
on pretreatment liver CT remains beneficial.
The A4/MHA origin detection rate is much higher,
which has several important benefits. Depending on the
hepatic arterial configuration of an individual patient, it
can be decided to use the A4/MHA as a separate site of
administration, include it in a more proximal injection po-
sition or coil-embolize it to induce intrahepatic redistribu-
tion of blood flow [4, 10]. Furthermore, it allows pretreat-
ment activity calculations to be performed with knowledge
of the segment 4 vascularisation. This is crucial to avoid
under- or overdosing of segment 4 when performing
radioembolisation on a single-session basis, and it may
contribute to a more reliable distribution of 99mTC-
macroaggregated albumin (99mTc-MAA) during a routine
pretreatment procedure [11, 12]. Interestingly, we found
that the typical distinction of segment 4 into an upper
(4a) and lower (4b) segment as based on the portal vascu-
larisation, could only be made in 11–19 % of patients.
The radiologists in our centre prefer the early arterial
phase for vascular evaluation due to the increased ease of
use associated with the higher CNR on maximum inten-
sity projections. It should, however, be noted that the 10-s
delay can be too short to allow for optimal enhancement
of hypervascular tumours. In these patients, the use of an
early and late arterial phase (10- and 20-s post-threshold
delay, respectively) may be considered if no other imag-
ing is available to substitute tumour evaluation.
C-arm CT has vastly improved the possibilities for intra-
procedural imaging. It allows for 3D-imaging of contrast-
enhanced vessels in relation to surrounding soft tissue, and
we have previously demonstrated that C-arm CT is capable
Table 4 Origin detection of the
A4/middle hepatic artery (MHA)
on CT
Entire cohort (n = 94) Standard protocol (n = 48) Adjusted protocol (n = 46)
Origin of A4/MHAvisible?
Rater 1
Yes 90 (96 %) 46 (96 %) 44 (96 %)
No 4 (4 %) 2 (4 %) 2 (4 %)
Rater 2
Yes 84 (89 %) 42 (87 %) 42 (91 %)
No 10 (11 %) 6 (13 %) 4 (9 %)
A4/MHA origins
Rater 1
CHA 4 (4 %) 1 (2 %) 3 (7 %)
PHA 3 (3 %) 3 (7 %) 0
LHA 51 (57 %) 28 (61 %) 23 (52 %)
rLHA 2 (2 %) 1 (2 %) 1 (2 %)
RHA 25 (28 %) 13 (28 %) 12 (27 %)
rRHA 0 0 0
LHA + RHA 4 (4 %) 0 4 (9 %)
rLHA + RHA 1 (1 %) 0 1 (2 %)
Rater 2
CHA 4 (5 %) 1 (2 %) 3 (7 %)
PHA 4 (5 %) 4 (10 %) 0 (0 %)
LHA 47 (56 %) 26 (62 %) 21 (50 %)
rLHA 1 (1 %) 1 (2 %) 0
RHA 23 (27 %) 10 (24 %) 13 (31 %)
rRHA 0 0 0
LHA + RHA 4 (5 %) 0 4 (10 %)
rLHA + RHA 1 (1 %) 0 1 (2 %)
The A4/MHA origin and its detection rate are summarized for both raters in this table, for the entire cohort and for
both protocols separately
Values are given in number of patients (percentage of total)
CHA common hepatic artery, PHA proper hepatic artery, LHA left hepatic artery, RHA right hepatic artery
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of showing the intra- and extrahepatic arterial perfusion
territory of target branches during radioembolisation work-
up [13]. It may, therefore, be regarded as the new gold
standard for vascular evaluation. Unfortunately, we could
not use C-arm CT as a reference standard because it was
not available in all patients treated before 2013. We used
DSA instead for the RGA origin detection. This was
deemed unfeasible for the A4 origin detection, due to chal-
lenges posed by overprojection of intrahepatic branches on
the 2D DSA-images and lack of soft-tissue landmarks. It
should be noted that the excellent capacities of C-arm CT
do not render optimization of pre-procedural imaging use-
less. An accurate assessment of the hepatic arterial anato-
my before the preparatory angiography enables discussing
and defining a treatment strategy ahead of time, and in-
creases time-efficiency as well as operator confidence dur-
ing the preparatory angiography [4].
Our study had several limitations. First, our sample size was
based on an assumption of a reasonable number of patients to
compare the two protocol groups, because specific detection
rates for this study population were lacking. However, baseline
characteristics were comparable. Furthermore, we allowed raters
to use bothMIP and non-MIP images to detect the RGA and A4
origins. For CNR assessment, we used MIP images only. We
believe that this has contributed to the difference in results for the
CNRmeasurements and origin detection assessments. In clinical
practice radiologists are, however, not restricted to a specific
method to evaluate images. In addition, we tried to blind the
raters for the type of protocol used in a scan, but because the
difference in CNR was so explicit and the gastric preparation
was slightly different in the two protocols, they could still dif-
ferentiate between the two protocol types. Finally, we only eval-
uated the origin of the RGA and A4, because these branches are
present in all patients and have important implications. However,
in some patients other small arterial branches are also important,
such as the artery to segment 1, extrahepatic branches to the
pancreas or duodenum, and parasitized extrahepatic arteries.
Further research needs to clarify whether these branches and
their origin can be visualized on pretreatment CT.
CT hardware and acquisition protocols are continually
evolving. In this study, we focused on the arterial phase delay
timing, but changes in other technical parameters may lead to
further improvements of the liver CTacquisition protocol. The
use of a higher contrast agent concentration and injection rate,
a patient-tailored scan delay based on a test bolus of contrast
agent, and scanning at lower energy levels are among the most
promising developments [6, 14, 15].
Conclusion
A 10-s delay arterial phase protocol does not significantly im-
prove the detection rate of small intra- and extrahepatic
branches, despite an increased CNR of the hepatic arteries rel-
ative to the portal vein. Ease of use with this protocol needs to
be weighed against the lesser sensitivity for hypervascular tu-
mour detection. The RGA origin detection rate is currently
suboptimal, whereas the A4/MHAorigin detection rate is much
higher, with good inter-rater reproducibility. Nevertheless, CT
remains important for preprocedural planning, because it may
reveal arterial anatomy not discernible on DSA.
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